Logos Global Management LP Quant / Systematic

CIK: 0001792126 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $926,849 (100.0% shares, 0.0% debt)

Holdings (55)

IDYA IDEAYA BIOSCIENCES INC 7.2%
Value ($000) $66,528 Shares 2,100,000 Est. Cost $24.47 Unrealized +54.9%
GPCR STRUCTURE THERAPEUTICS INC 5.9%
Value ($000) $54,863 Shares 1,250,000 Est. Cost $38.03 Unrealized
RVMD REVOLUTION MEDICINES INC 5.9%
Value ($000) $54,420 Shares 1,200,000 Est. Cost $37.38 Unrealized +16.5%
IRON DISC MEDICINE INC 5.0%
Value ($000) $45,946 Shares 935,000 Est. Cost $34.12 Unrealized +37.6%
JANX JANUX THERAPEUTICS INC 4.9%
Value ($000) $45,430 Shares 1,000,000 Est. Cost $42.31 Unrealized +2.8%
OLMA OLEMA PHARMACEUTICALS INC 4.1%
Value ($000) $38,314 Shares 3,208,875 Est. Cost $42.01 Unrealized -69.6%
PCVX VAXCYTE INC 3.7%
Value ($000) $34,281 Shares 300,000 Est. Cost $90.12 Unrealized 0.0%
IMVT IMMUNOVANT INC 3.4%
Value ($000) $31,361 Shares 1,100,000 Est. Cost $24.70 Unrealized +19.4%
CLDX CELLDEX THERAPEUTICS INC NEW 3.3%
Value ($000) $30,591 Shares 900,000 Est. Cost $38.10 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 3.3%
Value ($000) $30,450 Shares 3,500,000 Est. Cost $4.25 Unrealized +94.1%
IONS IONIS PHARMACEUTICALS INC 3.2%
Value ($000) $30,045 Shares 750,000 Est. Cost $44.32 Unrealized +5.0%
ERAS ERASCA INC 3.2%
Value ($000) $29,757 Shares 10,900,000 Est. Cost $2.46 Unrealized +14.5%
APLS APELLIS PHARMACEUTICALS INC 3.1%
Value ($000) $28,840 Shares 1,000,000 Est. Cost $50.24 Unrealized -26.3%
MERUS N V 3.1%
Value ($000) $28,727 Shares 575,000 Est. Cost $59.17 Unrealized
GLPG GALAPAGOS NV 2.5%
Value ($000) $23,032 Shares 800,000 Est. Cost $28.79 Unrealized
AKERO THERAPEUTICS INC 2.5%
Value ($000) $22,952 Shares 800,000 Est. Cost $34.92 Unrealized
DSGN DESIGN THERAPEUTICS INC 2.4%
Value ($000) $22,691 Shares 4,217,627 Est. Cost $19.27 Unrealized -75.6%
VERA VERA THERAPEUTICS INC 2.4%
Value ($000) $22,100 Shares 500,000 Est. Cost $37.23 Unrealized +1.9%
COGT COGENT BIOSCIENCES INC 2.3%
Value ($000) $21,600 Shares 2,000,000 Est. Cost $9.74 Unrealized 0.0%
CYTK CYTOKINETICS INC 2.3%
Value ($000) $21,120 Shares 400,000 Est. Cost $55.74 Unrealized 0.0%
BCAX BICARA THERAPEUTICS INC 2.2%
Value ($000) $20,376 Shares 800,000 Est. Cost $25.50 Unrealized 0.0%
SRPT SAREPTA THERAPEUTICS INC 2.0%
Value ($000) $18,734 Shares 150,000 Est. Cost $122.50 Unrealized +12.9%
ANNX ANNEXON INC 1.7%
Value ($000) $15,392 Shares 2,600,000 Est. Cost $4.01 Unrealized +47.8%
TVTX TRAVERE THERAPEUTICS INC 1.7%
Value ($000) $15,389 Shares 1,100,000 Est. Cost $10.42 Unrealized 0.0%
ELVN ENLIVEN THERAPEUTICS INC 1.4%
Value ($000) $12,642 Shares 495,000 Est. Cost $16.32 Unrealized +41.9%
BEAM BEAM THERAPEUTICS INC 1.3%
Value ($000) $12,250 Shares 500,000 Est. Cost $25.84 Unrealized 0.0%
EWTX EDGEWISE THERAPEUTICS INC 1.3%
Value ($000) $12,011 Shares 450,000 Est. Cost $19.89 Unrealized 0.0%
BCYC BICYCLE THERAPEUTICS PLC 1.2%
Value ($000) $11,315 Shares 500,000 Est. Cost $22.63 Unrealized
Y-MABS THERAPEUTICS INC 1.1%
Value ($000) $10,520 Shares 800,000 Est. Cost $13.15 Unrealized
ARVN ARVINAS INC 1.1%
Value ($000) $9,852 Shares 400,000 Est. Cost $26.11 Unrealized 0.0%
TRVI TREVI THERAPEUTICS INC 1.0%
Value ($000) $9,185 Shares 2,750,000 Est. Cost $2.35 Unrealized +26.6%
NUVL NUVALENT INC 0.8%
Value ($000) $7,673 Shares 75,000 Est. Cost $71.13 Unrealized +16.6%
CMPS COMPASS PATHWAYS PLC 0.8%
Value ($000) $7,302 Shares 1,159,030 Est. Cost $6.34 Unrealized
ORKA ORUKA THERAPEUTICS INC 0.7%
Value ($000) $6,307 Shares 257,330 Est. Cost $34.79 Unrealized 0.0%
RCKT ROCKET PHARMACEUTICALS INC 0.6%
Value ($000) $6,003 Shares 325,000 Est. Cost $18.43 Unrealized +11.2%
SYRE SPYRE THERAPEUTICS INC 0.6%
Value ($000) $5,882 Shares 200,000 Est. Cost $27.55 Unrealized +1.1%
DYN DYNE THERAPEUTICS INC 0.6%
Value ($000) $5,747 Shares 160,000 Est. Cost $16.98 Unrealized +134.4%
ASTRIA THERAPEUTICS INC 0.6%
Value ($000) $5,505 Shares 500,000 Est. Cost $14.31 Unrealized
FULC FULCRUM THERAPEUTICS INC 0.6%
Value ($000) $5,355 Shares 1,500,000 Est. Cost Unrealized
HELP CYBIN INC 0.6%
Value ($000) $5,334 Shares 600,000 Est. Cost $9.89 Unrealized 0.0%
ENGN ENGENE HOLDINGS INC 0.6%
Value ($000) $5,280 Shares 800,000 Est. Cost $12.43 Unrealized -40.2%
AVTX AVALO THERAPEUTICS INC 0.6%
Value ($000) $5,121 Shares 539,079 Est. Cost $12.97 Unrealized -20.5%
LCTX LINEAGE CELL THERAPEUTICS IN 0.5%
Value ($000) $4,527 Shares 5,000,000 Est. Cost $1.12 Unrealized -17.3%
RAPP RAPPORT THERAPEUTICS INC 0.4%
Value ($000) $4,065 Shares 208,910 Est. Cost $23.15 Unrealized -7.2%
SLN SILENCE THERAPEUTICS PLC 0.4%
Value ($000) $3,636 Shares 200,000 Est. Cost $20.06 Unrealized
ATYR ATYR PHARMA INC 0.4%
Value ($000) $3,520 Shares 2,000,000 Est. Cost $1.28 Unrealized +41.9%
NEXTCURE INC 0.4%
Value ($000) $3,425 Shares 2,500,000 Est. Cost $2.08 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.3%
Value ($000) $2,925 Shares 416,666 Est. Cost $14.14 Unrealized
ARTV ARTIVA BIOTHERAPEUTICS INC 0.2%
Value ($000) $2,130 Shares 145,089 Est. Cost $11.59 Unrealized 0.0%
UNICYCIVE THERAPEUTICS INC 0.2%
Value ($000) $2,072 Shares 5,078,927 Est. Cost $0.72 Unrealized
ALLAKOS INC 0.2%
Value ($000) $1,894 Shares 2,900,000 Est. Cost $6.04 Unrealized
NMRA NEUMORA THERAPEUTICS INC. 0.1%
Value ($000) $1,321 Shares 100,000 Est. Cost $12.27 Unrealized -5.0%
IOBT IO BIOTECH INC 0.1%
Value ($000) $519 Shares 493,827 Est. Cost $1.76 Unrealized -28.4%
SKYE SKYE BIOSCIENCE INC 0.0%
Value ($000) $391 Shares 100,000 Est. Cost $11.84 Unrealized -52.6%
BOLD BOUNDLESS BIO INC 0.0%
Value ($000) $204 Shares 58,903 Est. Cost $14.25 Unrealized -74.6%